Adicet Bio, Inc. · LS:A41X5V

Adicet Bio, Inc. financial statements

Adicet Bio, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue00025.0M9.73M17.9M995.0K8.18M558.5M547.0M
Cost of revenue6.38M6.47M6.10M5.01M125.0K80.0K5.00K411.5M
Gross profit-6.38M-6.47M-6.10M25.0M9.73M17.9M995.0K8.10M558.5M135.4M
Research and development99.1M99.3M106.0M71.2M48.9M34.3M23.7M14.7M16.8M5.94M
Selling, general and administrative23.0M28.3M26.5M26.3M22.2M22.8M8.69M8.43M76.8M73.2M
Operating income-122.1M-127.6M-152.0M-72.6M-61.4M-39.2M-31.4M-15.0M-18.9M-1.00K
Depreciation and amortization6.38M6.47M6.10M2.58M1.54M1.23M1.24M1.22M5.00K11.8M
EBITDA-115.7M-121.1M-145.9M-70.0M-59.9M-38.0M-30.1M-13.7M-18.9M11.8M
Interest expense36.0K4.00K25.0K80.0K176.0K134.0K7.00M3.95M
Income before tax-116.8M-117.1M-142.7M-69.8M-62.1M-39.5M-28.1M-9.89M-33.8M-1.00K
Income tax0000-125.0K-2.81M19.0K-589.0K020.4M
Net income-116.8M-117.1M-142.7M-69.8M-62.0M-36.7M-28.1M-9.30M-33.8M-1.00K
Earnings per share, basic-16.95-21.33-3.31-1.70-2.00-5.01-13.15-4.78-8.42-0.00
Earnings per share, diluted-16.95-21.33-3.31-1.70-2.00-5.01-13.15-4.78-8.42

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents38.9M56.5M159.7M257.7M277.5M84.3M10.6M9.47M53.3M66.8M
Short-term investments119.6M119.8M0010.3M51.8M101.0M0881.0K
Receivables342.0K435.0K214.0K2.73M935.0K260.9M167.6M
Inventory2.57M4.68M-3.09M672.0K136.4M98.1M
Current assets160.9M180.1M162.3M261.0M282.4M100.3M64.2M109.5M55.2M352.7M
Property, plant and equipment16.5M22.5M26.8M28.7M14.6M2.79M2.12M321.0K39.0K
Goodwill019.5M19.5M20.1M237.0M67.9M
Total assets192.4M220.2M207.3M330.7M338.9M153.8M81.6M109.9M55.2M540.8M
Accounts payable4.74M4.83M2.63M4.40M3.26M1.55M1.05M2.99M1.51M46.0M
Current liabilities21.5M19.4M19.3M19.7M16.3M22.5M14.9M5.72M5.50M98.9M
Total debt14.7M17.2M20.9M21.0M20.9M21.6M114.1M3.11M353.7M118.8M
Total liabilities33.1M33.6M37.1M38.4M35.8M44.0M27.9M5.74M5.50M236.3M
Shareholders' equity159.2M186.6M170.2M292.3M303.1M109.8M-60.4M-33.5M-26.9M304.4M
Shares outstanding9.59M5.16M43.3M43.0M39.7M39.7M2.16M28.1M5.66M1.75M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-95.2M-92.4M-93.7M-44.8M-51.1M-41.6M-27.9M-18.2M-11.0M8.34M
Capital spending-1.74M-1.12M-4.46M-16.8M-13.0M-990.0K-1.07M-876.0K-44.0K-617.0K
Free cash flow-97.0M-93.5M-98.2M-61.5M-64.1M-42.5M-29.0M-19.1M-11.0M7.73M
Cash from investing2.39M-119.2M-4.46M-16.8M-2.80M115.2M-47.9M-16.1M-44.0K-8.97M
Cash from financing75.2M111.3M236.0K41.5M242.7M303.0K76.9M11.0M64.4M-8.24M
Dividends paid-7.08M-6.96M
Share buybacks-150.0K-3.23M-55.7M-66.8M
Change in cash-17.6M-100.3M-97.9M-20.0M188.8M74.0M1.13M-23.2M53.3M-8.88M